Tesaro Inc (TSRO) financial statements (2020 and earlier)

Company profile

Business Address 1000 WINTER STREET, SUITE 3300
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments643786230257130125
Cash and cash equivalents643786230257130125
Receivables5351   
Inventory, net of allowances, customer advances and progress billings58151 
Inventory58151   
Prepaid expense and other current assets1
Other current assets349524
Total current assets:788815236259134127
Noncurrent Assets
Property, plant and equipment1073100
Intangible assets, net (including goodwill)561315 
Intangible assets, net (excluding goodwill)561315   
Restricted cash and investments321   
Other noncurrent assets64141
Prepaid expense and other noncurrent assets1
Total noncurrent assets:742519511
TOTAL ASSETS:862840255264136127
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1597445271513
Accounts payable458623
Accrued liabilities155683717119
Employee-related liabilities   421
Deferred revenue and credits 01   
Other liabilities732200
Other undisclosed current liabilities0  (4)(2)(1)
Total current liabilities:1667747241212
Noncurrent Liabilities
Long-term debt and lease obligation437     
Long-term debt, excluding current maturities437     
Liabilities, other than long-term debt10200 0 
Customer advances or deposits 15    
Deferred revenue and credits  0   
Other liabilities1050 0 
Other undisclosed noncurrent liabilities0132121115  
Total noncurrent liabilities:4471521221150 
Total liabilities:6132291681401212
Stockholders' equity
Stockholders' equity attributable to parent24961187124123116
Common stock000000
Additional paid in capital1,7251,605689475303203
Accumulated other comprehensive loss(6)(3)    
Accumulated deficit(1,470)(991)(602)(351)(179)(87)
Total stockholders' equity:24961187124123116
TOTAL LIABILITIES AND EQUITY:862840255264136127

Income statement (P&L) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues223450   
Revenue, net 450   
Cost of revenue
(Cost of Goods and Services Sold)
(41)(1)(0)   
Gross profit:182440   
Operating expenses(703)(416)(236)(167)(92)(62)
Other undisclosed operating income4110   
Operating loss:(480)(371)(236)(167)(92)(62)
Nonoperating income410000
Investment income, nonoperating410000
Interest and debt expense(20)(16)(15)4  
Loss from continuing operations before equity method investments, income taxes:(495)(386)(251)(163)(92)(62)
Other undisclosed loss from continuing operations before income taxes   (8)  
Loss from continuing operations before income taxes:(495)(386)(251)(171)(92)(62)
Income tax expense(1)(1)    
Net loss available to common stockholders, diluted:(496)(387)(251)(171)(92)(62)

Comprehensive Income ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(496)(387)(251)(171)(92)(62)
Other comprehensive income33    
Comprehensive loss:(493)(385)(251)(171)(92)(62)
Other undisclosed comprehensive loss, net of tax, attributable to parent(6)(6)    
Comprehensive loss, net of tax, attributable to parent:(499)(390)(251)(171)(92)(62)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: